Louis S. Camilli serves as Executive at L2 MEDICAL DEVELOPMENT CO, where they oversee executive responsibilities. Since joining the company, Louis S. Camilli has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 4, 2013 involved transacting 450,436 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 4, 2013 | SCQO | $0 | Other | 450,436 | $N/A | Discretionary |
Louis S. Camilli currently holds 450,436 shares of L2 MEDICAL DEVELOPMENT CO (SCQO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louis S. Camilli has been a net neutral trader of SCQO stock. They have purchased $0 and sold $0 worth of shares.
Louis S. Camilli's most recent insider trade was on Sep 4, 2013, when they sold 450,436 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted